Long‐term dienogest administration in patients with symptomatic adenomyosis

Abstract

Our report suggests that dienogest is tolerable for long-term use until menopause and can be an alternative treatment option in some patients, especially those with type 2 adenomyosis, to avoid hysterectomy.